Yasueda H, Kikuchi Y, Kojima H, Nagase K
Central Research Laboratories, Ajinomoto Co., Kanagawa, Japan.
Appl Microbiol Biotechnol. 1991 Nov;36(2):211-5. doi: 10.1007/BF00164422.
Human interleukin 6 (hIL-6) overproduced in Escherichia coli HB101 was found to partially retain the initiator methionine (Met) residue (Met-hIL-6). In order to remove the residual N-terminal Met in vivo, an attempt was made to express hIL-6 in aminopeptidase-P (Ap-P)-hyperproducing strains, since the N-terminus Met-Pro- structure of nascent recombinant hIL-6 has been shown to be a favoured substrate of the enzyme in vitro. Using a mutant with duplicated Ap-P genes (pepP) on a chromosome or some recombinant strains overproducing Ap-P, we have succeeded in removing the initiator Met from Met-hIL-6 in vivo. The content of the mature product without the initiator Met in the pepP recombinant strains could be increased to approximately 99% from 85%.
在大肠杆菌HB101中过量产生的人白细胞介素6(hIL-6)被发现部分保留起始甲硫氨酸(Met)残基(Met-hIL-6)。为了在体内去除残留的N端甲硫氨酸,尝试在氨基肽酶-P(Ap-P)高产菌株中表达hIL-6,因为新生重组hIL-6的N端Met-Pro-结构已被证明在体外是该酶的有利底物。使用在染色体上具有重复Ap-P基因(pepP)的突变体或一些过量产生Ap-P的重组菌株,我们已成功在体内从Met-hIL-6中去除起始甲硫氨酸。pepP重组菌株中不含起始甲硫氨酸的成熟产物含量可从85%提高到约99%。